Methicillin-resistant Staphylococcus aureus
Showing 1 - 25 of 5,972
Initial and Chronic Methicillin Resistant Staphylococcus Aureus
Completed
- Methicillin-Resistant Staphylococcus Aureus
- Cystic Fibrosis
- Intervention N/A. Observational study
-
Birmingham, Alabama
- +2 more
Jan 19, 2022
Multidrug Resistant Bacterial Infection, Enterobacteriaceae Infections, Pseudomonas Aeruginosa Trial in Philadelphia (PMT)
Not yet recruiting
- Multidrug Resistant Bacterial Infection
- +4 more
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
Nov 17, 2022
Methicillin-resistant Staphylococcus Aureus Infection Trial in Falls Church, Leesburg (Preoperative MRSA screening)
Terminated
- Methicillin-resistant Staphylococcus Aureus Infection
- Preoperative MRSA screening
-
Falls Church, Virginia
- +1 more
Jun 3, 2021
MRSA Bloodstream Infection, MRSA Bacteremia, MRSA Right-sided Endocarditis Trial in Butte, Toledo (Exebacase)
No longer available
- MRSA Bloodstream Infection
- +3 more
-
Butte, Montana
- +1 more
Aug 25, 2022
CA-MRSA Transmission: An ED Population Sampling Strategy
Recruiting
- Methicillin-Resistant Staphylococcus Aureus
- Acute Abscess Group
-
Gainesville, FloridaUF Health
Jun 4, 2021
Cystic Fibrosis, Methicillin-resistant Staphylococcus Aureus Trial in Cleveland (Vancomycin)
Withdrawn
- Cystic Fibrosis
- Methicillin-resistant Staphylococcus Aureus
-
Cleveland, OhioRainbow Babies and Children's Hospital, Univeristy Hospitals Cas
Dec 23, 2021
Infection Control Trial in Baltimore (Enhanced cleaning of surfaces in ICU rooms, Sham enhanced cleaning of surfaces in ICU
Completed
- Infection Control
- Enhanced cleaning of surfaces in ICU rooms
- Sham enhanced cleaning of surfaces in ICU rooms
-
Baltimore, MarylandUniversity of Maryland, Baltimore
Feb 15, 2022
Healthy Volunteers, Anti-Bacterial Agents, Methicillin-Resistant Staphylococcus Aureus Trial in Seoul (N-Rephasin® SAL200,
Completed
- Healthy Volunteers
- +3 more
- N-Rephasin® SAL200
- INT200-Placebo
-
Seoul, Korea, Republic ofSeoul National University Hospital
Oct 26, 2021
Bacteremia Due to Staphylococcus Aureus, Left Sided Infective Endocarditis (Disorder), Right Sided Infective Endocarditis
Withdrawn
- Bacteremia Due to Staphylococcus Aureus
- +3 more
- Tonabacase (LSVT-1701)
-
Butte, MontanaLsvt-1701-2001
Jun 27, 2022
Healthy Volunteers, Anti-Bacterial Agents, Methicillin-Resistant Staphylococcus Aureus Trial in Seoul (N-Rephasin® SAL200,
Completed
- Healthy Volunteers
- +2 more
- N-Rephasin® SAL200
- INT200-Placebo
-
Seoul, Korea, Republic ofSeoul National University Hospital
Oct 7, 2021
Bacteremia Due to Methicillin Susceptible Staphylococcus Aureus Trial in Paris (Cloxacillin, Cefazolin)
Recruiting
- Bacteremia Due to Methicillin Susceptible Staphylococcus Aureus
-
Paris, FranceFrançois-Xavier Lescure
Dec 7, 2022
Methicillin-Resistant Staphylococcus Aureus, Bacterial Infections, Staphylococcal Skin Infections Trial in Worldwide
Recruiting
- Methicillin-Resistant Staphylococcus Aureus
- +2 more
- Dalbavancin single dose
- +2 more
-
Mobile, Alabama
- +26 more
Jan 27, 2023
Emergencies Trial (GeneXpert®)
Withdrawn
- Emergencies
- GeneXpert®
- (no location specified)
Nov 9, 2020
Antistaphylococcal Betalactam and Emergence of Resistance
Completed
- Bacterial Resistance
- Methicillin-Sensitive Staphylococcus Aureus Infection
-
Nancy, Lorraine, FranceLefevre
Jul 1, 2023
Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Septicemia, Staphylococcal Sepsis Trial in Montreal (Ertapenem, Placebo)
Not yet recruiting
- Staphylococcus Aureus Bacteremia
- +3 more
- Ertapenem
- Placebo
-
Montreal, Quebec, CanadaMcGill University Health Centre (Royal Victoria Hospital and Mon
Feb 21, 2022
Methicillin-resistant Staphylococcus Aureus Trial in United States (Standard-of-Care Education, MRSA Decolonization)
Completed
- Methicillin-resistant Staphylococcus Aureus
- Standard-of-Care Education
- MRSA Decolonization
-
Aliso Viejo, California
- +23 more
Sep 27, 2021
Methicillin-resistant Staphylococcus Aureus Trial in Saint John (Rifampin, Doxycycline, 2% mupirocin ointment)
Completed
- Methicillin-resistant Staphylococcus Aureus
- Rifampin
- +3 more
-
Saint John, New Brunswick, CanadaSaint John Regional Hospital
Feb 12, 2020
Methicillin-Resistant Staphylococcus Aureus Trial (intervention)
Completed
- Methicillin-Resistant Staphylococcus Aureus
- intervention
- (no location specified)
Mar 26, 2020
MRSA, Cystic Fibrosis Trial in Canada, United States (Vancomycin inhalation powder, Placebo inhalation powder)
Completed
- MRSA
- Cystic Fibrosis
- Vancomycin inhalation powder
- Placebo inhalation powder
-
Mobile, Alabama
- +70 more
Nov 4, 2021
Staphylococcus Aureus, Carbapenem Resistant Gram Negative Bacteria Trial (Targeted gown and gloves use)
Not yet recruiting
- Staphylococcus Aureus
- Carbapenem Resistant Gram Negative Bacteria
- Targeted gown and gloves use
- (no location specified)
Oct 26, 2021
Patients With Infection by Resistant Microorganism
Enrolling by invitation
- Pneumonia
- +10 more
- Pathogen resistant phenotype
-
Sevilla, SpainHospital Universitario Virgen Macarena
May 18, 2023
Gram-negative Bacilli and MRSA Screening in ICU in China
Unknown status
- Infections, Bacterial
- None intervention. This is an observational study.
-
Hangzhou, Zhejiang, ChinaSir Run Run Shaw Hospital
Mar 18, 2020
Staphylococcus Aureus Trial in Philadelphia (Bacillus subtilis probiotic, Placebo)
Unknown status
- Staphylococcus Aureus
- Bacillus subtilis probiotic
- Placebo
-
Philadelphia, PennsylvaniaRothman Institute
Feb 18, 2020
Patients withInfections Caused by S.Aureus Like Skin Infections , Chest Infections , Surgical Site Infections , and Urinary
Not yet recruiting
- Patients withInfections Caused by S.Aureus Like Skin Infections , Chest Infections , Surgical Site Infections , and Urinary Tract Infections
- antibiotic sensitivity
-
Sohag, EgyptSohag University Hospital
Apr 13, 2023